Home NDC 0074-5925 JUVMO
Product NDC 0074-5925
11-digit product format 000745925
Labeler code 0074
Product ID 0074-5925_1cbfaa3b-d541-4ac3-bf4e-9ab82d8d1b6c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tavapadon
Dosage form TABLET
Route ORAL
Labeler AbbVie Inc.
Application NDA220415
Marketing category NDA
Marketing start 2026-09-25
Substance TAVAPADON
Active strength .25 mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N220415-001 JUVMO (COPACKAGED) TAVAPADON 0.25MG;1MG TABLET / ORAL RLD, RS 2026-09-25 N220415-002 JUVMO TAVAPADON 5MG TABLET / ORAL RLD, RS 2026-09-25 N220415-003 JUVMO TAVAPADON 10MG TABLET / ORAL RLD 2026-09-25 N220415-004 JUVMO TAVAPADON 15MG TABLET / ORAL RLD 2026-09-25
Orange Book patents# Current patent rows page 1 of 1 · 16 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N220415-001 10093655 2034-06-23 U-219 2026-10-22 N220415-001 10421744 2034-06-23 U-219 2026-10-22 N220415-001 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 N220415-001 9527831 2034-06-23 Drug substance, Drug product 2026-10-22 N220415-002 10093655 2034-06-23 U-219 2026-10-22 N220415-002 10421744 2034-06-23 U-219 2026-10-22 N220415-002 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 N220415-002 9527831 2034-06-23 Drug substance, Drug product 2026-10-22 N220415-003 10093655 2034-06-23 U-219 2026-10-22 N220415-003 10421744 2034-06-23 U-219 2026-10-22 N220415-003 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 N220415-003 9527831 2034-06-23 Drug substance, Drug product 2026-10-22 N220415-004 10093655 2034-06-23 U-219 2026-10-22 N220415-004 10421744 2034-06-23 U-219 2026-10-22 N220415-004 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 N220415-004 9527831 2034-06-23 Drug substance, Drug product 2026-10-22
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N220415-001 JUVMO (COPACKAGED) 0.25MG;1MG TABLET / ORAL RLD, RS 2026-09-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-002 JUVMO 5MG TABLET / ORAL RLD, RS 2026-09-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-003 JUVMO 10MG TABLET / ORAL RLD 2026-09-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-004 JUVMO 15MG TABLET / ORAL RLD 2026-09-25 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N220415-001 JUVMO (COPACKAGED) 0.25MG;1MG TABLET / ORAL RLD 2026-09-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N220415-002 JUVMO 5MG TABLET / ORAL RLD 2026-09-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N220415-003 JUVMO 10MG TABLET / ORAL RLD 2026-09-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N220415-004 JUVMO 15MG TABLET / ORAL RLD, RS 2026-09-25 c2088c7a36db…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N220415-001 10093655 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-001 10421744 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-001 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-001 9527831 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-002 10093655 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-002 10421744 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-002 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-002 9527831 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-003 10093655 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-003 10421744 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-003 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-003 9527831 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-004 10093655 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-004 10421744 2034-06-23 U-219 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-004 9107923 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-004 9527831 2034-06-23 Drug substance, Drug product 2026-10-22 d4dbc9d85df4…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-11-14 07:37:17 2026-10 N220415-001 NCE 2031-09-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-002 NCE 2031-09-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-003 NCE 2031-09-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N220415-004 NCE 2031-09-25 d4dbc9d85df4…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base JUVMO
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TAVAPADON .25 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination PT4P8MJP8L Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 12 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2754365 Internal RxNorm lookup 2754371 Internal RxNorm lookup 2754373 Internal RxNorm lookup 2754375 Internal RxNorm lookup 2754377 Internal RxNorm lookup 2754379 Internal RxNorm lookup 2754381 Internal RxNorm lookup 2754383 Internal RxNorm lookup 2754385 Internal RxNorm lookup 2754387 Internal RxNorm lookup 2754388 Internal RxNorm lookup 2754389 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0074-5925-21 00074592521 21 TABLET in 1 BLISTER PACK (0074-5925-21) 21 tablet 2026-09-25 Yes No Current